Stakeholders’ Perceptions of Medication for the Treatment of Opioid Use Disorder: Factors Influencing Patient Uptake and Retention
Funded by: Center for Drug Use and HIV Research
Project dates: March 2020 - August 2021
Principal Investigator: Frank, David

This study used semi-structured interviews with key stakeholders in Medication for the Treatment of Opioid Use Disorder, to examine potential differences across treatment modalities (e.g., MMT vs. buprenorphine, clinic-based vs. office-based), and among individual treatment programs/providers (e.g., abstinence-based vs. harm reduction), in how these different approaches function in regards to patient satisfaction, and uptake of and retention in, Medication for the Treatment of Opioid Use Disorder. Findings will be used to to establish feasibility and informing the development of more specific research questions and/or hypotheses and appropriate research design to address them.